Newsletter
Industry Watch
With fall in the air in the northern hemisphere, it’s also a week full of noteworthy news in clinical development. New research shines a light on…
Featured Insights
Ask the Experts: Understanding Juvenile Idiopathic Arthritis
In light of JIA Awareness Month, its treatments, its stigma, and more, we spoke with Dr. Johnny Peppers, Executive Director of Drug Development for…
PRA Teams with Microsoft to Enhance COVID-19 Monitoring
Over the past several months, participants in PRA Health Sciences’ Health Harmony COVID-19 Monitoring Program have had vital information about…
All Insights
Newsletter
Blog
PRA Health Sciences and Deep Lens, Inc. partner to accelerate patient recruitment for precision cancer trials.
This strategic relationship brings together best-in-class technologies that improve the identification, screening, and matching of cancer patients to…
Blog
Global Voices: Celebrating Mexican Independence Day with Luis Bolanos
September 16 marks Día de la Independencia (Mexican Independence Day), the anniversary of Mexico’s independence from Spain. This day is designated as…
Case Study
Collaboration Advances Small Pharma Company’s Pediatric Development Plan to First-in-Pediatrics RSV Study
A Phase II, randomized, double-blind, placebo-controlled, 2-part study to evaluate the safety, tolerability, pharmacokinetics, clinical response, and…
Blog
In the News: Innovative Methods on the Horizon for Diagnosing Alzheimer’s
A recent study shows that a blood test can detect Alzheimer’s disease early in its progression. It’s as accurate as other more invasive, expensive…
Newsletter
Industry Watch
In the second week of September, we bring news of leading drug developers coming together to pledge to uphold safety standards amidst the rush to…
Blog
LLS PedAL: How Collaboration in Pediatric Oncology Trials Will Lead to Success
PRA has partnered with The Leukemia and Lymphoma Society (LLS) on a global precision medicine clinical trial for children with relapsed acute…
Blog
Ask the Experts: Why Do We Need to Talk About Suicide?
Suicide is a difficult topic to discuss—it’s painful for those who've seen suicide affect their loved ones. And yet, it affects us all on a global…
White Paper
Data Sharing & Anonymization - Current Overview of Data Sharing within Clinical Trial Transparency
Clinical trial transparency has emerged in recent years as a key function within pharmaceutical and academic organizations. Although trial…
White Paper
Plain Language Summaries - Keeping the End in Mind: Key Considerations for Creating Plain Language Summaries
Plain language summaries (PLS), also known as lay summaries and trial results summaries, educate participants and the public about clinical trial…